PURPOSE: To reduce or prevent neuronal death which normally occurs in the case of stroke and nerve function disorder followed by the death. CONSTITUTION: In a method of treats of a subject currently afflicted with a stroke or previously afflicted with an ischemic event, the method comprises administering a therapeutically effective amount of metabotropic glutamate receptor agonist to the subject.
USE OF METABOLIZING GLUTAMATE RECEPTOR AGONIST IN TREATMENT OF BRAIN ISCHEMIA